APA

Turgeon J., Evans W. E., Relling M. V., Wilkinson G. R. & Roden D. M. (19920311). Phenotypic debrisoquine 4-hydroxylase activity among extensive metabolizers is unrelated to genotype as determined by the Xba-I restriction fragment length polymorphism. : British journal of clinical pharmacology.

Chicago

Turgeon J, Evans W E, Relling M V, Wilkinson G R and Roden D M. 19920311. Phenotypic debrisoquine 4-hydroxylase activity among extensive metabolizers is unrelated to genotype as determined by the Xba-I restriction fragment length polymorphism. : British journal of clinical pharmacology.

Harvard

Turgeon J., Evans W. E., Relling M. V., Wilkinson G. R. and Roden D. M. (19920311). Phenotypic debrisoquine 4-hydroxylase activity among extensive metabolizers is unrelated to genotype as determined by the Xba-I restriction fragment length polymorphism. : British journal of clinical pharmacology.

MLA

Turgeon J, Evans W E, Relling M V, Wilkinson G R and Roden D M. Phenotypic debrisoquine 4-hydroxylase activity among extensive metabolizers is unrelated to genotype as determined by the Xba-I restriction fragment length polymorphism. : British journal of clinical pharmacology. 19920311.